student discount windows 8 purchase access 2007 online cheap office 2003 pro cost of microsoft office suite microsoft excel best buy buy microsoft office project server 2007 buy digital copy of windows 7 buy windows 7 online price of adobe acrobat 9 pro purchase adobe photoshop 7.0 best price cs3 mac best price final cut express 4 best price microsoft office 2010 home and business buy quicken 2007 deluxe order wordperfect x4
buy vmware fusion 3 mac buy ms office 2007 small business oem price of flash cs4 best price ms office 2007 price of photoshop cs2 cheap adobe fireworks cs4 buy mathcad pricing buy mac os x snow leopard buy office outlook 2007 only buy adobe photoshop cc 2014 commercial buy captivate 5 best price filemaker pro 11 download win xp professional oem order office 2007 buy nik software complete collection

New Breath Test to Identify Head and Neck Cancer

Wed, May 11, 2011

Oral Cancer News

Source: British Journal of Cancer

M Hakim, S Billan, U Tisch, G Peng, I Dvrokind, O Marom, R Abdah-Bortnyak, A Kuten and H Haick



Head-and-neck cancer (HNC) is the eighth most common malignancy worldwide. It is often diagnosed late due to a lack of screening methods and overall cure is achieved in <50% of patients. Head-and-neck cancer sufferers often develop a second primary tumour that can affect the entire aero-digestive tract, mostly HNC or lung cancer (LC), making lifelong follow-up necessary.


Alveolar breath was collected from 87 volunteers (HNC and LC patients and healthy controls) in a cross-sectional clinical trial. The discriminative power of a tailor-made Nanoscale Artificial Nose (NA-NOSE) based on an array of five gold nanoparticle sensors was tested, using 62 breath samples. The NA-NOSE signals were analysed to detect statistically significant differences between the sub-populations using (i) principal component analysis with ANOVA and Student’s t-test and (ii) support vector machines and cross-validation. The identification of NA-NOSE patterns was supported by comparative analysis of the chemical composition of the breath through gas chromatography in conjunction with mass spectrometry (GC–MS), using 40 breath samples.


The NA-NOSE could clearly distinguish between (i) HNC patients and healthy controls, (ii) LC patients and healthy controls, and (iii) HNC and LC patients. The GC–MS analysis showed statistically significant differences in the chemical composition of the breath of the three groups.


The presented results could lead to the development of a cost-effective, fast, and reliable method for the differential diagnosis of HNC that is based on breath testing with an NA-NOSE, with a future potential as screening tool.


Print Friendly
Be Sociable, Share!
, , , ,

Leave a Reply

You must be logged in to post a comment.